Monoclinic BiVO4powders were synthesized via a novel route using potassium metavanadate (KVO3) prepared by calcination of K2CO3and V2O5as a starting material and followed by hydrothermal treatment and were investigated for the degradation of Rhodamine B (RhB) under visible light irradiation. The synthesized BiVO4particles were characterized by X-ray diffraction (XRD), scanning electron microscopy (SEM), X-ray photoelectron spectroscopy (XPS), and UV-Visible (UV-Vis) light diffuse reflectance spectrophotometry. The synthesis produced pure monoclinic BiVO4particles with multimorphological features containing flower-like, flake-ball, flake, cuboid-like, and plate-like shapes and exhibited strong absorption in the visible light range. The BiVO4prepared via KVO3possessed excellent photocatalytic activity for the degradation of RhB under visible light. The performance of this catalyst was found to be superior to other BiVO4photocatalysts prepared via ammonium metavanadate (NH4VO3) using coprecipitation, combustion, and calcination methods reported in literature, respectively.
No takes yet. Share an insight, caveat, or question.
Ran et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: